Out of step with Europe
A review of 11 cases shows that pharmaceutical patents in Russia are being upheld despite having been invalidated in Europe. Yana Lipatova says companies should carefully review the grounds in each case
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: